J P Vannier - JoVE Visualize

Showing results (71-80 of 129) with videos related to

Pageof 13

Sort By:

Medical and Pediatric Oncology|January 1, 1994

Treatment of relapsed or refractory acute leukemia in childhood with bisantrene combined with high dose aracytineT Leblanc, F Deméocq, G Leverger, et al.

Annales Pharmaceutiques Francaises|August 18, 2004

[Protein Z: a new regulator of coagulation in arterial vessels?]M Vasse, Chr Denoyelle, E Guégan-Massardier, et al.

Bone Marrow Transplantation|January 1, 1993

Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD): the French experience. GEGMOF Bernaudin, G Souillet, J P Vannier, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 26, 2002

Oncostatin M induces procoagulant activity in human vascular smooth muscle cells by modulating the balance between tissue factor and tissue factor pathway inhibitorF Mirshahi, M Vasse, A Tedgui, et al.

Annals of the New York Academy of Sciences|July 20, 2001

Fibrinogen: a vascular risk factor, why? Contributing effect of oncostatin M on both fibrinogen biosynthesis by hepatocytes and participation in atherothrombotic risk related to modifications of endothelial cellsF Mirshahi, M Vasse, L Vincent, et al.

Biology of the Neonate|June 12, 1999

Erythropoietin blood level is increased in sudden infant deathV Le Cam-Duchez, A Coquerel, F Chevallier, et al.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1990

New evaluations of circulating granulocyte and macrophage stem cells in healthy adults using conditioned media and recombinant human growth factorsJ P Vannier, E Sumereau-Dassin, P Jean, et al.

Contraception, Fertilite, Sexualite (1992)|April 7, 1999

[Malignant non-seminomatous germinal tumors of the ovary. Experience of the French Society of Pediatric Oncology. 64 cases]M C Baranzelli, C Patte, E Bouffet, et al.

Human Reproduction (Oxford, England)|October 24, 2008

Fertility preservation in adolescent males: experience over 22 years at Rouen University HospitalS Menon, N Rives, N Mousset-Siméon, et al.

FEBS Letters|May 4, 2001

Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effectL Vincent, W Chen, L Hong, et al.

Pageof 13

Showing results (71-80 of 129) with videos related to

Sort By:

Pageof 13

Medical and Pediatric Oncology|January 1, 1994

Treatment of relapsed or refractory acute leukemia in childhood with bisantrene combined with high dose aracytineT Leblanc, F Deméocq, G Leverger, et al.

Annales Pharmaceutiques Francaises|August 18, 2004

[Protein Z: a new regulator of coagulation in arterial vessels?]M Vasse, Chr Denoyelle, E Guégan-Massardier, et al.

Bone Marrow Transplantation|January 1, 1993

Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD): the French experience. GEGMOF Bernaudin, G Souillet, J P Vannier, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 26, 2002

Oncostatin M induces procoagulant activity in human vascular smooth muscle cells by modulating the balance between tissue factor and tissue factor pathway inhibitorF Mirshahi, M Vasse, A Tedgui, et al.

Annals of the New York Academy of Sciences|July 20, 2001

Fibrinogen: a vascular risk factor, why? Contributing effect of oncostatin M on both fibrinogen biosynthesis by hepatocytes and participation in atherothrombotic risk related to modifications of endothelial cellsF Mirshahi, M Vasse, L Vincent, et al.

Biology of the Neonate|June 12, 1999

Erythropoietin blood level is increased in sudden infant deathV Le Cam-Duchez, A Coquerel, F Chevallier, et al.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1990

New evaluations of circulating granulocyte and macrophage stem cells in healthy adults using conditioned media and recombinant human growth factorsJ P Vannier, E Sumereau-Dassin, P Jean, et al.

Contraception, Fertilite, Sexualite (1992)|April 7, 1999

[Malignant non-seminomatous germinal tumors of the ovary. Experience of the French Society of Pediatric Oncology. 64 cases]M C Baranzelli, C Patte, E Bouffet, et al.

Human Reproduction (Oxford, England)|October 24, 2008

Fertility preservation in adolescent males: experience over 22 years at Rouen University HospitalS Menon, N Rives, N Mousset-Siméon, et al.

FEBS Letters|May 4, 2001

Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effectL Vincent, W Chen, L Hong, et al.

Pageof 13